ATE308621T1 - Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer - Google Patents

Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer

Info

Publication number
ATE308621T1
ATE308621T1 AT00401568T AT00401568T ATE308621T1 AT E308621 T1 ATE308621 T1 AT E308621T1 AT 00401568 T AT00401568 T AT 00401568T AT 00401568 T AT00401568 T AT 00401568T AT E308621 T1 ATE308621 T1 AT E308621T1
Authority
AT
Austria
Prior art keywords
production
gene transfer
retroviral constructs
replicating
replicating retroviral
Prior art date
Application number
AT00401568T
Other languages
English (en)
Inventor
David Klatzmann
Arnaud Morel
Georg Holzer
Jean-Loup Salzmann
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of ATE308621T1 publication Critical patent/ATE308621T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00401568T 1999-06-09 2000-06-05 Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer ATE308621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99401391A EP1059357A1 (de) 1999-06-09 1999-06-09 Replizierende oder 'semi-replizierende' retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer

Publications (1)

Publication Number Publication Date
ATE308621T1 true ATE308621T1 (de) 2005-11-15

Family

ID=8242006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00401568T ATE308621T1 (de) 1999-06-09 2000-06-05 Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer

Country Status (6)

Country Link
US (1) US6485965B1 (de)
EP (1) EP1059357A1 (de)
JP (1) JP2001000195A (de)
AT (1) ATE308621T1 (de)
CA (1) CA2307933A1 (de)
DE (1) DE60023600T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2386646B1 (de) * 1998-10-01 2016-12-21 University Of Southern California Genlieferungssystem und Verwendungsverfahren
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
ATE527347T1 (de) 2001-08-02 2011-10-15 Inst Clayton De La Rech Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
GB0220467D0 (en) 2002-09-03 2002-10-09 Oxford Biomedica Ltd Composition
EP2055316A1 (de) * 2003-09-09 2009-05-06 VIRxSYS Corporation Lentivirale, vektorbasierte Ansätze zur Erzeugung einer Immunantwort auf HIV bei Menschen
WO2005098049A2 (en) * 2004-03-25 2005-10-20 California Institute Of Technology Hybridization chain reaction
WO2006058231A2 (en) * 2004-11-24 2006-06-01 Nanovector Limited Viral vectors
US7727721B2 (en) 2005-03-08 2010-06-01 California Institute Of Technology Hybridization chain reaction amplification for in situ imaging
EP1931806B1 (de) 2005-10-07 2011-10-05 California Institute Of Technology Pkr-aktivierung mittels hybridisierungskettenreaktion
WO2008106658A2 (en) * 2007-03-01 2008-09-04 California Institute Of Technology TRIGGERED RNAi
WO2008144562A1 (en) 2007-05-16 2008-11-27 California Institute Of Technology A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
US8497364B2 (en) * 2008-02-27 2013-07-30 California Institute Of Technology Triggered RNAi
US20100021904A1 (en) * 2008-05-21 2010-01-28 Pierce Niles A Shielded cross-linking probes
US20100021901A1 (en) * 2008-05-22 2010-01-28 Peng Yin Compositions and methods for detecting analytes
US8241854B2 (en) 2008-05-22 2012-08-14 California Institute Of Technology Triggered RNAi
US8658780B2 (en) 2010-05-18 2014-02-25 California Institute Of Technology Triggered covalent probes for imaging and silencing genetic expression
US8962241B2 (en) 2010-07-20 2015-02-24 California Institute Of Technology Triggered molecular geometry based bioimaging probes
US9834439B2 (en) 2010-07-20 2017-12-05 California Institute Of Technology Biomolecular self-assembly
US8877438B2 (en) 2010-07-20 2014-11-04 California Institute Of Technology Self-assembled polynucleotide structure
ES2786051T3 (es) 2012-10-25 2020-10-08 Tocagen Inc Vector retroviral con casete de mini-promotor
US9856472B2 (en) 2013-07-01 2018-01-02 California Institute Of Technology Small conditional RNAs
IL290679B2 (en) 2016-07-05 2023-10-01 California Inst Of Techn Hybridization chain reaction based on a minimal initiator
CA3034617A1 (en) 2016-08-30 2018-03-08 California Institute Of Technology Immunohistochemistry via hybridization chain reaction
US11540872B2 (en) 2017-03-13 2023-01-03 Covidien Lp Electrosurgical instrument with trigger driven cutting function
WO2022164796A1 (en) 2021-01-26 2022-08-04 California Institute Of Technology Allosteric conditional guide rnas for cell-selective regulation of crispr/cas
CN116478939B (zh) * 2023-06-20 2023-09-08 天津瑞普生物技术股份有限公司 表达禽脑脊髓炎病毒p1和3c基因的重组禽痘病毒及其构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834256A (en) * 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
FR2751345B1 (fr) * 1996-07-16 1998-09-18 Univ Paris Curie Lignees d'encapsidation hautement productrices
US5869035A (en) 1996-11-13 1999-02-09 Human Gene Therapy Research Institute Methods and compositions for inducing complement destruction of tissue

Also Published As

Publication number Publication date
EP1059357A1 (de) 2000-12-13
CA2307933A1 (en) 2000-12-09
JP2001000195A (ja) 2001-01-09
DE60023600D1 (de) 2005-12-08
US6485965B1 (en) 2002-11-26
DE60023600T2 (de) 2006-08-10

Similar Documents

Publication Publication Date Title
DE60023600D1 (de) Replizierende retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer
DE69828045D1 (de) Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen
PT2302063T (pt) Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo
DE69535540D1 (de) Zusammensetzung enthaltend nukleinsäuren und kationische polymere, zubereitung und verwendung
ATE300613T1 (de) Menschliche, für zyklische nukleotide spezifische phosphodiesterase
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
PT1210357E (pt) Oligonucleótido-tiofosforamidatos n3'→p5': sua síntese e utilização
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
DE69906977D1 (de) In liposomen verkapselte nukleinsäurekomplexe
ATE281837T1 (de) Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation
DE69635609D1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
DE60042821D1 (de) 6-alkenyl, 6-alkynyl und 6-epoxy- epothilon-derivate. verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zusammensetzungen
DE69719220D1 (de) Neue nucleotidanaloga
WO2000006705A3 (de) Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
DE59915205D1 (de) Strukturprotein von AAV, seine Herstellung und Verwendung
ZA971158B (en) Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs.
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
DE50208824D1 (de) Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen
DE69817180D1 (de) Zns neuroregenerative zusammensetzungen und deren verwendungen
HUP0004577A1 (hu) Kationos nukleinsav transzfekciós ágensek új csoportja
ATE428793T1 (de) Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
ATE355385T1 (de) Herstellung von rekombinanten adenoviren und von adenovirus-genbanken
AU4395599A (en) (-)-strand rna virus vector for nerve cell
DE60030428D1 (de) 4-cyano-3-hydroxy-butanoyl hydrazine, derivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties